AMH and polycystic ovary syndrome: Due to the established challenges associated with successfully diagnosing PCOS, including the limitations within the assessment of the current diagnostic criteria [17–21], the use of the Elecsys AMH Plus immunoassay as a substitute for determining PCOM is expected to be beneficial for the primary care setting in the UK.